AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Grafnos 2.0 Capsule

Prescription Icon
Prescription Required

Marketer

Akognos Life Sciences

Salt Composition

Tacrolimus (2mg)

Overview Grafnos 2.0 Capsule

TransGuard 2.0 capsules are used in conjunction with other medications to prevent organ rejection following transplantation (e.g., liver, kidney, heart). Their mechanism involves suppressing the immune system to prevent the body from attacking the new organ. This medication is classified as an immunosuppressant. Dosage and frequency of TransGuard 2.0 are determined by transplant type, patient weight, and concomitant medications; strictly adhere to your physician's prescribed regimen. Administer on an empty stomach, at least one hour before or two hours after eating. Consistent use is crucial for optimal efficacy; discontinuation increases the risk of transplant rejection. TransGuard 2.0 carries potential side effects, including exacerbation or onset of diabetes and kidney issues, requiring immediate medical attention. Other possible side effects, such as tremor, infections, hypertension, headache, and sleep disturbances, warrant reporting to your doctor if persistent or worsening. Immunosuppression increases susceptibility to infections. Inform your physician of pre-existing conditions like kidney, liver, or heart disease, diabetes, or hypertension before commencing treatment. Disclosure of all other medications, particularly those for infections, pain, or arthritis, is essential due to potential interactions. Minimize sun and UV exposure due to increased skin cancer risk associated with immunosuppressants. Reliable contraception is necessary for both men and women during treatment. Use during pregnancy or breastfeeding is generally discouraged unless medically indicated. Regular medical monitoring, including frequent blood pressure checks, is required throughout treatment.

Primary Ingredients of Grafnos 2.0 Capsule

No text provided to rephrase.

Uses of Grafnos 2.0 Capsule

Avoiding transplant organ rejection

Major Benefits of Grafnos 2.0 Capsule:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Consume Grafnos 2.0 Capsules on an empty stomach.

Common Side effects of Grafnos 2.0 Capsule:

  • High blood pressure
  • Increased glucose level in blood
  • Kidney damage
  • Insomnia (difficulty in sleeping)
  • Tremors
  • Headache
  • Abnormal liver function tests
  • Infection

How to use Grafnos 2.0 Capsule:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest Grafnos 2.0 Capsules on an empty stomach.

How Grafnos 2.0 Capsule works:

Immunosuppressant Grafnos 2.0 Capsules reduce the body's immune reaction after organ transplantation (such as liver, kidney, or heart). This action facilitates the body's acceptance of the transplanted organ.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Alcohol consumption alongside Grafnos 2.0 Capsules is strongly discouraged due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Grafnos 2.0 Capsules during pregnancy may pose risks. While human research is insufficient, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Grafnos 2.0 Capsules while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingUNSAFE

Using Grafnos 2.0 Capsules might reduce alertness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.

KidneyKidneyCAUTION

Exercise caution when administering Grafnos 2.0 Capsules to individuals with impaired kidney function. Dosage modification for Grafnos 2.0 Capsules may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with hepatic impairment should exercise caution when using Grafnos 2.0 Capsules. Dosage modification of Grafnos 2.0 Capsules may be necessary. Physician consultation is recommended.

What if you forget to take Grafnos 2.0 Capsule :

Should you forget a Grafnos 2.0 Capsule dose, take it immediately. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Grafnos 2.0 Capsule

LabelValue
Chemical Category Macrolide Antibiotics
Developing Habits No.
Type of Therapy Cancer Medications

FAQs on Grafnos 2.0 Capsule

Grafnos 2.0 Capsules are macrolide antibiotics primarily used post-organ transplant. Their immunosuppressive action helps prevent rejection following kidney, heart, or liver transplantation.
While using Grafnos 2.0 Capsules, avoid live vaccines like measles, mumps, rubella, BCG, yellow fever, chickenpox, and typhoid vaccines. Also avoid oral polio vaccine and nasal flu vaccine.
Grafnos 2.0 Capsules are contraindicated for patients with allergies, weakened immune systems, high blood pressure, or kidney failure. Pregnant or breastfeeding women, and individuals scheduled for live vaccines (such as MMR), should also avoid this medication.
Before starting treatment, tell your doctor about any pregnancies, allergies, chronic infections, high blood sugar, high blood pressure, high potassium levels, or weakened immunity. Also, disclose your medication history, recent vaccines, and any upcoming live vaccines.
Grafnos 2.0 Capsules suppress the immune system, increasing the risk of infection and, in some cases, certain cancers such as skin and lymphoma. This medication weakens your body's ability to fight infections. Consult your doctor before use, and immediately if you experience any infection symptoms, including fever, chills, sweats, cough, flu-like symptoms, muscle aches, or skin redness, warmth, or pain.
Grafnos 2.0 Capsules are not controlled substances and do not possess abuse potential. Controlled substances require authorization from medical professionals and regulatory bodies due to their inherent risk of misuse.
Grafnos 2.0 Capsule
891